Back to Search
VIGNAN MANNE, MD
MD
Gastroenterology Physician
NPI: 1346660420IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD60759252(WA)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
19095(NV)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
OTHER
Class of 2012
Research & Publications (13)
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily.
PMID 19260711·J Med Chem·2009
7-preclinical
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.
PMID 18690676·J Med Chem·2008
7-preclinical
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors.
PMID 18479916·Bioorg Med Chem Lett·2008
7-preclinical
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
PMID 18289854·Bioorg Med Chem Lett·2008
7-preclinical
Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors.
PMID 15837622·Cancer Cell·2005
7-preclinical
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.
PMID 15780629·Bioorg Med Chem Lett·2005
7-preclinical
Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors.
PMID 15710949·J Clin Oncol·2005
3-trial
Apoptotic and cytostatic farnesyltransferase inhibitors have distinct pharmacology and efficacy profiles in tumor models.
PMID 15173010·Cancer Res·2004
7-preclinical
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.
PMID 11606387·Cancer Res·2001
7-preclinical
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.
PMID 11020273·J Med Chem·2000
7-preclinical
3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors.
PMID 10698452·Bioorg Med Chem Lett·2000
8-other
Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension.
PMID 10642341·Hypertension·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1707 W CHARLESTON BLVD STE 230
LAS VEGAS, NV 89102 - Phone
- (702) 671-2507
Quick Facts
- NPI
- 1346660420
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 14
- Publications
- 13
Are you this provider?
Claim Your Profile